Involvement of miRNAs in the Differentiation of Human Glioblastoma Multiforme Stem-Like Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Aldaz, Beatriz ^a,c   Sagardoy, Ainara ^a   Nogueira, Lorena ^b   Guruceaga, Elizabeth ^a   Grande, Lara ^b   Huse, Jason T ^c   Aznar, Maria A ^a   Díez Valle, Ricardo ^d   Tejada Solís, Sonia ^d   Alonso, Marta M ^a   Fernandez Luna, Jose L ^b   Martinez Climent, Jose A ^a   Malumbres, Raquel ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 106A; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 29A; MICRORNA 29B; MICRORNA 93; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CANCER STEM CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GLIOBLASTOMA MULTIFORME STEM LIKE CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; MLC1 GENE; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; SPRY1 GENE;

ANIMALS; APOPTOSIS; ASTROCYTES; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICRORNAS; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NEOPLASTIC STEM CELLS; NESTIN; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; SPHEROIDS, CELLULAR; TUBULIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84885392997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077098     Document Type: Article

References (48)

1. Miller CR, Perry A, (2007) Glioblastoma. Arch Pathol Lab Med 131: 397-406. PubMed: 17516742.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996. doi:10.1056/NEJMoa043330. PubMed: 15758009.
3. Vescovi AL, Galli R, Reynolds BA, (2006) Brain tumour stem cells. Nat Rev_Cancer 6: 425-436. PubMed: 16723989.
4. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, et al. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021. doi:10.1158/0008-5472.CAN-04-1364. PubMed: 15466194.
5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401. doi:10.1038/nature03128. PubMed: 15549107.
6. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760. doi:10.1038/nature05236. PubMed: 17051156.
7. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, et al. (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765. doi:10.1038/nature05349. PubMed: 17151667.
8. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, et al. (2010) Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res Off J Am Assoc Cancer Res 16: 2715-2728. doi:10.1158/1078-0432.CCR-09-1800. PubMed: 20442299.
9. Nogueira L, Ruiz-Ontañon P, Vazquez-Barquero A, Lafarga M, Berciano MT, et al. (2011) Blockade of the NFkappaB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo. Oncogene 30: 3537-3548. doi:10.1038/onc.2011.74. PubMed: 21423202.
10. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233. doi:10.1016/j.cell.2009.01.002. PubMed: 19167326.
11. Kawase-Koga Y, Low R, Otaegi G, Pollock A, Deng H, et al. (2010) RNAase-III enzyme Dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci 123: 586-594. doi:10.1242/jcs.059659. PubMed: 20103535.
12. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. doi:10.1038/nature03702. PubMed: 15944708.
13. Godlewski J, Newton HB, Chiocca EA, Lawler SE, (2010) MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ 17: 221-228. doi:10.1038/cdd.2009.71. PubMed: 19521422.
14. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14. doi:10.1186/1741-7015-6-14. PubMed: 18577219.
15. Mathupala SP, Guthikonda M, Sloan AE, (2006) RNAi based approaches to the treatment of malignant glioma. Technol Cancer Res Treat 5: 261-269. PubMed: 16700622.
16. Ruiz-Ontañon P, Orgaz JL, Aldaz B, Elosegui-Artola A, Martino J, et al. (2013) Cellular Plasticity Confers Migratory and Invasive Advantages to a Population of Glioblastoma-initiating Cells that Infiltrate Peritumoral Tissue. Stem Cells, 31: 1075-85. PubMed: 23401361.
17. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828. PubMed: 14522905.
18. Cormack B, (2001) Directed mutagenesis using the polymerase chain reaction. Curr Protoc Neurosci Chapter 4Unit 411. PubMed: 1826527718428475.
19. Beltran E, Fresquet V, Martinez-Useros J, Richter-Larrea JA, Sagardoy A, et al. (2011) A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma. Proc Natl Acad Sci U S A 108: 12461-12466. doi:10.1073/pnas.1018941108. PubMed: 21746927.
20. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol, 3: 3. PubMed: 16646809.
21. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868. doi:10.1073/pnas.95.25.14863. PubMed: 9843981.
22. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15. doi:10.1093/nar/gng015. PubMed: 12582260.
23. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105. PubMed: 18955434.
24. Lall S, Grün D, Krek A, Chen K, Wang YL, et al. (2006) A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol 16: 460-471. doi:10.1016/j.cub.2006.01.050. PubMed: 16458514.
25. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284. doi:10.1038/ng2135. PubMed: 17893677.
26. Betel D, Wilson M, Gabow A, Marks DS, Sander C, (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36: D149-D153. doi:10.1093/nar/gkn715. PubMed: 18158296.
27. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158. doi:10.1093/nar/gkn221. PubMed: 17991681.
28. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, et al. (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100: 15178-15183. doi:10.1073/pnas.2036535100. PubMed: 14645703.
29. Jung JE, Moon SH, Kim DK, Choi C, Song J, et al. (2012) Sprouty1 regulates neural and endothelial differentiation of mouse embryonic stem cells. Stem Cells Dev 21: 554-561. doi:10.1089/scd.2011.0110. PubMed: 21595564.
30. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984. doi:10.1038/nature07511. PubMed: 19043405.
31. Ma X, Kumar M, Choudhury SN, Becker Buscaglia LE, Barker JR, et al. (2011) Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci U S A 108: 10144-10149. doi:10.1073/pnas.1103735108. PubMed: 21646541.
32. Mott JL, Kobayashi S, Bronk SF, Gores GJ, (2007) mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140. doi:10.1038/sj.onc.1210436. PubMed: 17404574.
33. Guo J, Niu R, Huang W, Zhou M, Shi J, et al. (2012) Growth factors from tumor microenvironment possibly promote the proliferation of glioblastoma-derived stem-like cells in vitro. Pathol Oncol Res 18: 1047-1057. doi:10.1007/s12253-012-9543-7. PubMed: 22996727.
34. Kim TM, Huang W, Park R, Park PJ, Johnson MD, (2011) A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res 71: 3387-3399. doi:10.1158/0008-5472.CAN-10-4117. PubMed: 21385897.
35. Liu Y, Namba T, Liu J, Suzuki R, Shioda S, et al. (2010) Glial fibrillary acidic protein-expressing neural progenitors give rise to immature neurons via early intermediate progenitors expressing both glial fibrillary acidic protein and neuronal markers in the adult hippocampus. Neuroscience 166: 241-251. doi:10.1016/j.neuroscience.2009.12.026. PubMed: 20026190.
36. Jiang Y, Boije M, Westermark B, Uhrbom L, (2011) PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation. Neoplasia 13: 492-503. PubMed: 21677873.
37. Gao FB, (2008) Posttranscriptional control of neuronal development by microRNA networks. Trends Neurosci 31: 20-26. doi:10.1016/j.tins.2007.10.004. PubMed: 18054394.
38. Day BW, Stringer BW, Spanevello MD, Charmsaz S, Jamieson PR, et al. (2011) ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1. Neuro-oncology.
39. Zhang J, Han L, Ge Y, Zhou X, Zhang A, et al. (2010) miR-221/222 promote malignant progression of glioma through activation of the Akt pathway. Int J Oncol 36: 913-920. PubMed: 20198336.
40. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, et al. (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A 102: 18081-18086. doi:10.1073/pnas.0506216102. PubMed: 16330772.
41. Gomes AL, Reis-Filho JS, Lopes JM, Martinho O, Lambros MB, et al. (2007) Molecular alterations of KIT oncogene in gliomas. Cell Oncol 29: 399-408. PubMed: 17726262.
42. Hamada N, Fujita Y, Kojima T, Kitamoto A, Akao Y, et al. (2012) MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation. Neurochem Int 60: 743-750. doi:10.1016/j.neuint.2012.03.010. PubMed: 22465943.
43. Zhi F, Chen X, Wang S, Xia X, Shi Y, et al. (2010) The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer (Oxf, England: 1990) 46:: 1640-1649. PubMed: 20219352.
44. Papagiannakopoulos T, Shapiro A, Kosik KS, (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68: 8164-8172. doi:10.1158/0008-5472.CAN-08-1305. PubMed: 18829576.
45. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, et al. (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67: 8994-9000. doi:10.1158/0008-5472.CAN-07-1045. PubMed: 17908999.
46. Zhou X, Zhang J, Jia Q, Ren Y, Wang Y, et al. (2010) Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. Oncol Rep 24: 195-201. PubMed: 20514462.
47. Singh SK, Kagalwala MN, Parker-Thornburg J, Adams H, Majumder S, (2008) REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 453: 223-227. doi:10.1038/nature06863. PubMed: 18362916.
48. Faedo A, Borello U, Rubenstein JL, (2010) Repression of Fgf signaling by sprouty1-2 regulates cortical patterning in two distinct regions and times. J Neurosci Off J Soc Neurosci 30: 4015-4023. doi:10.1523/JNEUROSCI.0307-10.2010. PubMed: 20237272.